SCHEMBL6153787

SCHEMBL6153787

O=[N+]([O-])c1ccc(-c2cnc(Nc3ccc(Oc4ccccc4)cc3)s2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 4/20 0.54
ROCK1 Q13464 1/20 0.47
FFAR1 O14842 1/20 0.47
XDH P47989 1/20 0.47
ALDH1A1 P00352 2/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
ALOX15 P16050 1/20 0.46
CYP2C19 P33261 1/20 0.46
TTBK1 Q5TCY1 1/20 0.46
TTBK2 Q6IQ55 1/20 0.46
HPGD P15428 1/20 0.46
ALOX12 P18054 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 2/20 0.44
MAPT P10636 2/20 0.44
MAPK1 P28482 2/20 0.44
KMT2A Q03164 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20379651 0.89 KDR (0.68) KDRROCK1XDHALDH1A1CYP3A4
SCHEMBL6336620 0.85 KDR (0.74) KDRROCK1
SCHEMBL20389301 0.82 KMO (0.55) KDRROCK1XDHALDH1A1CYP3A4
SCHEMBL28067065 0.75 XDH (0.56) XDHALDH1A1CYP3A4CYP2C9ALOX15
SCHEMBL5353883 0.75 KDR (0.53) KDRCYP2C9CYP2C19L3MBTL1MEN1
SCHEMBL6282681 0.74 CNR1 (0.70) KDRALDH1A1MEN1MAPTKMT2A
SCHEMBL3596386 0.74 KDR (0.72) KDRROCK1ALDH1A1HPGDKDM4E
SCHEMBL6332010 0.74 KDR (0.72) KDRROCK1ALDH1A1CYP3A4CYP2D6
SCHEMBL20379759 0.73 XDH (0.76) XDHALDH1A1CYP3A4CYP2C9HPGD
Hydrochloric Acid SCHEMBL28805026 0.72 XDH (0.55) XDHALDH1A1KDM4EMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP KDR 2876/4885ROCK1 3290/4885FFAR1 4172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.